Skip to main content
. 2019 Oct 10;36(4):301–309. doi: 10.5114/biolsport.2019.88752

TABLE 2.

Summary of primary data for association between PPARGC1A Gly482Ser polymorphism and power performance.

Authors Year Country Ethnicity Group Number (N) Genotype (N) MAF PHWE NOS Score
Gly/Gly Gly/Ser Ser/Ser
Eynon et al. 2010 Israeli Caucasian Case Control 81 35 36 10 0.346 0.9529 7
240 79 117 44 0.427
Ginevičienė et al. 2011 Lithuanian Caucasian Case Control 51 29 21 1 0.225 0.5177 9
250 129 104 17 0.276
Maciejewska et al. 2012 Polish Caucasian Case Control 210 118 79 13 0.25 0.8938 8
684 280 314 90 0.361
Russian Caucasian Case Control 724 329 322 73 0.323 0.6651
1132 489 505 138 0.345
Gineviciene et al. 2016 Russian Caucasian Case Control 114 62 35 17 0.303 0.7450 8
947 424 416 107 0.333
Lithuanian Caucasian Case Control 47 24 22 1 0.255 0.4860
255 132 106 17 0.275
Peplonska et al. 2017 Polish Caucasian Case Control 188 97 73 18 0.290 0.0871 6
451 199 213 39 0.323
Guilherme et al. 2018 Brazilian Caucasian Case Control 314 173 116 25 0.264 0.6187 7
893 428 385 80 0.305

MAF = minor allele frequency, P HWE = P value for Hardy–Weinberg equilibrium of controls, NOS = Newcastle-Ottawa Scale.